NCT00436423View on ClinicalTrials.gov

A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 31, 2006

Conditions
Pancreatic NeoplasmNeoplasm Metastasis
Interventions
DRUG

gemcitabine, TS-1

Trial Locations (1)

136-705

YeulHong Kim, Seoul

All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Seoul Municipal Boramae Hospital

UNKNOWN

collaborator

Konkuk University Hospital

OTHER

collaborator

Korea University Ansan Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Korea University Guro Hospital

OTHER

lead

Korea University Anam Hospital

OTHER

NCT00436423 - A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer | Biotech Hunter | Biotech Hunter